Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for cardiovascular drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, patent expiry of popular blockbuster drugs, increase in disposable income and introduction of newer and better drugs is helping the market to grow.

Heart disease, also known as cardiovascular disease, generally affects older people and means that there is a problem with the blood vessels and heart.

Heart disease is the leading cause of death in the United States. More than a quarter of all deaths from heart disease. These diseases including Angina, arteriosclerosis, atherosclerosis, heart attack, and stroke. Some risk factors for heart disease include

Cardiovascular fitness speak about the healthiness of the heart and blood vessels. It in addition relay to the health of organs that are seriously reliant on a well-built blood provide. Protection of cardiovascular health and avoidance of cardiovascular sickness are the focal point of the National Historic Preservation Act.